CNS Pharmaceuticals ( CNSP ), Inc. on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive form of brain cancer. The trial compared Berubicin to Lomustine, a current standard of care in recurrent or progressive GBM. This analysis did not demonstrate statistically significant superiority in overall survival, the primary endpoint....

* More bad news for Tesla * Changan drives into Europe * BYD juggernaut rolls on Tesla takes some more hits In the 22 years since it was founded, Tesla has experienced years of crisis, with no shortage of stock jumps and occasional slumps. And each slump is unique. Tesla has now seen two consecutive months of plunging sales and...

WASHINGTON (Reuters) - Boeing said on Tuesday it had ramped up production of a critical component for Patriot air defense interceptor missiles - the seeker that identifies and tracks efforts to knock them down - to meet growing demand from the U.S. and allies. Eighteen countries, including Ukraine, use PAC-3 interceptors, which have proven effective against advanced threats such as...

(Reuters) - Aurora Innovation ( AUR ) plans to allow its self-driving trucks to operate without a driver in inclement weather ahead of launching commercial trips this year in Texas, the company said on Tuesday. The autonomous trucks are expected to start operating on public roads in Texas, New Mexico, and Arizona in 2025, adhering to speed limits ranging from...